Ten‐year‐old boy with atypical COVID‐19 symptom presentation: A case report

Houshmand, Hamidreza; Abounoori, Mahdi; Ghaemi, Reza; Bayat, Sara; Houshmand, Gholamreza

doi:10.1002/ccr3.3521

Cited by 13 publications

(21 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another patient was reported by Roongta et al who describe a 56 year old woman who developed seropositive RA with joint symptoms starting 2–3 weeks after recovery from Covid-19 [ 35 ]. To date there is only one paediatric case described in the literature; a 10-year-old boy presented with oligoarthritis, fever and urticaria [ 36 ].…”

Section: Resultsmentioning

confidence: 99%

Rheumatological complications of Covid 19

Zacharias

Dubey

Koduri

et al. 2021

Autoimmunity Reviews

View full text Add to dashboard Cite

Introduction COVID-19 has caused unprecedented hardships in the 21st century with more than 150 million infections. Various immunological phenomena have been described during the course of the infection, and this infection has also triggered autoimmunity. Rheumatological illnesses have been described following resolution of the acute infection; hence we sought to conduct a review of the rheumatological complications of COVID-19. Methods We conducted a literature search for articles relating to sequelae of COVID-19 from Jan 2020 to 30th April 2021. Results We found a number of reports of inflammatory arthritis after SARS-CoV-2 infection. SLE and renal disease have been described, and vasculitis also appears to be a common complication. Rhabdomyolysis and myositis has also been reported in a number of patients. We also found some evidence of large vessel vasculitis in ‘long COVID’ patients. Conclusions This review highlights a number of important complications such as inflammatory arthritis, lupus-like disease, myostis and vasculitis following SARS-CoV-2 infection.

show abstract

Section: Resultsmentioning

confidence: 99%

Rheumatological complications of Covid 19

Zacharias

Dubey

Koduri

et al. 2021

Autoimmunity Reviews

View full text Add to dashboard Cite

show abstract

“…Associated cutaneous findings were reported in six cases and included maculopapular rash, urticaria, lesions consistent with psoriasis, palpable purpura, pruritic clearly demarcated erythematous scaly patches, and leukoderma with an associated unspecified rash. 12 , 15 , 18 , 24 , 32 , 39 The diagnostic work-up varied across cases with most authors reporting results of one or more inflammatory markers and auto-antibody panels. However, arthrocentesis with synovial fluid analysis was only reported for 19 cases.…”

Section: Resultsmentioning

confidence: 99%

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

et al. 2022

View full text Add to dashboard Cite

Background Given the widespread impact of COVID-19, it is important to explore any atypical presentations and long-term sequelae associated with this viral infection, including the precipitation of inflammatory arthritis. Objective To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19. Methods A systematic review of the PubMed (MEDLINE), Google Scholar, and Cochrane Central databases through January 31, 2022 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The inclusion criteria were: human subjects and English language. Data extraction and qualitative synthesis of the demographics, clinical presentations, treatments, and outcomes were performed. Quality assessment was performed using the Joanna-Briggs Institute critical appraisal tools. Results A total of 37 articles collectively describing the cases of 54 patients were included. The mean age was 48.2 years (6-78 years). 53.7% of patients were male and 46.3% were female. The onset of articular symptoms varied considerably, and the majority of cases were described as polyarticular (29). The classification of inflammatory arthritis in the included studies was as follows: reactive (19), post-viral (13), new-onset rheumatoid arthritis (RA) (8), crystal-proven arthropathy flare (4), acute viral (2), new-onset psoriatic arthritis (2), flare of preexisting RA (2), and other (4). Arthritis treatment regimens varied but consisted largely of NSAIDs and corticosteroids with most patients experiencing improvement or resolution of their joint symptoms. Conclusion There is limited low-level evidence suggesting that patients may develop acute arthritis during or after SARS-CoV-2 infection. This review highlights the need for further research to elucidate the relationship between COVID-19 and the development of inflammatory arthritis.

show abstract

“…This diagnosis remains possible in cases of early onset of articular symptoms. In this review, two cases of early arthritis associated with signs of disseminated viral infection were considered ReA [ 2 , 3 ]. Indeed, Houshmand et al described the case of a 10-year-old boy who presented with a concomitant fever, urticaria, and arthritis.…”

mentioning

confidence: 99%